- Practice your ROG trading strategies and win cash in our stock game.
Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.
The settlement provides Mylan with global licenses for its trastuzumab product.
Here is a round-up of the news from Europe.
The stock gaped to the downside Tuesday and has continued lower today.